SCHEMBL1805935

SCHEMBL1805935

CCOC(=O)c1c(C)n[nH]c1-c1ncccc1CN(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.46
TDP2 O95551 4/20 0.40
TRPV1 Q8NER1 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 1/20 0.38
MAPK10 P53779 1/20 0.38
ALDH1A1 P00352 3/20 0.38
POLB P06746 1/20 0.37
IDO1 P14902 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
BRD4 O60885 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806748 0.85 PDE4D (0.47) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1807386 0.82 PDE4D (0.43) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1808198 0.82 PDE4D (0.43) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1806318 0.81 PDE4D (0.50) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1807745 0.81 PDE4D (0.50) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1804789 0.80 PDE4D (0.46) PDE4DSMN1; SMN2HTTMAPK10ALDH1A1
SCHEMBL1807009 0.80 PDE4D (0.48) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1809756 0.78 PDE4D (0.46) PDE4DTDP2SMN1; SMN2HTTMAPK10
SCHEMBL1806341 0.76 TRPV1 (0.37) TRPV1ALDH1A1KDM4EMAPTHPGD
SCHEMBL1806019 0.75 TRPV1 (0.36) TRPV1ALDH1A1POLBKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501703-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060035-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed